IMMX — IMMIX BIOPHARMA INC

Ownership history in Imprint Wealth LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Imprint Wealth LLC reported a position in IMMIX BIOPHARMA INC (IMMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.49% (2025 Q4)
Avg. % of fund
0.19%
First filed
2023 Q2
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 20,009 -47,414 -70.3% 0.49% $105K $5.23
2025 Q3 ADDED 67,423 +41,209 +157.2% 0.45% $141K $2.09
2024 Q1 REDUCED 26,214 -8,269 -24.0% 0.02% $77K $3.07
2023 Q4 ADDED 34,483 +11,400 +49.4% 0.12% $143K $6.92
2023 Q3 REDUCED 23,083 -19,249 -45.5% 0.07% $79K $3.42
2023 Q2 INITIATED 42,332 — — 0.02% $42.3M $2.69
% of Fund (quarterly)    IMMX price (monthly, adj. close)

Other funds also holding IMMX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 2.88% Bleichroeder LP 3Y 0.92% Blue Owl Capital Holdings LP 3Y 0.39% Logos Global Management LP 3Y 0.32% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.21% Velan Capital Investment Management LP 3Y 0.11% Burkehill Global Management, LP 0.1% Persistent Asset Partners Ltd 0.07% Informed Momentum Co LLC 3Y 7Y 0.07% LGT Fund Management Co Ltd. 3Y 0.05%
← Back to Imprint Wealth LLC Holdings